Viking Acquisition Corp I (VACI-WT)
A warrant is a lottery ticket wrapped in a contract — it costs less to enter the game, but you can also go to zero faster than a shareholder who simply redeemed.
Viking Acquisition Corp I is a blank-check acquisition vehicle whose securities trade in two forms: common units (bundled shares and warrants) and warrants as a standalone instrument under the VACI-WT ticker. The warrant piece is where the leverage lives. When a shareholder buys a unit at the SPAC stage, they are purchasing a share of the trust account plus the right to buy additional shares later at a pre-set strike price. The warrant is only valuable if the post-merger company trades above that strike — and only then does the warrant holder have the choice to exercise and buy shares, or hold, or sell the warrant itself to someone else willing to bet on further upside.
Why warrants exist and what they cost
SPAC sponsors use warrants as a capital-raising and incentive tool. A retail investor who might be nervous about sinking $10 per share into a trust account feels differently about spending $10 for a unit that includes a warrant worth something on day one — especially if the warrant strikes at $11.50, meaning that once the merged company’s stock trades above $11.50, the warrant immediately has intrinsic value. The warrant also rewards sponsors for finding a good deal: if the merged company is worthless, the warrants expire worthless and sponsors do not get their founder warrants. If the company is phenomenal and trades at $25, a warrant with an $11.50 strike becomes a $13.50 asset (minus the warrant’s time decay and the risk that it will not be exercised).
But this amplification goes both ways. A warrant holder who buys VACI-WT is making a more aggressive bet than someone who owns the common shares. If the merged company trades at $9, the warrant is worthless and the holder has lost their entire investment, whereas the common shareholder still has their pro-rata claim on the trust account and any operating assets. Conversely, if the company trades at $15, the warrant is worth $3.50 (the spread between the stock price and the strike, less the cost the holder paid to acquire the warrant in the first place).
Mechanics and dilution
When a warrant is exercised, the holder pays the strike price to buy a share. That $11.50 goes to the company (not to whoever sold them the warrant), so from the company’s perspective, each exercise is a small capital raise. But for existing shareholders, each exercise dilutes their ownership — the share count goes up and their proportional stake goes down, even if the company’s total value hasn’t changed.
Most SPAC warrants have American exercise features, meaning holders can exercise any time until expiry (usually five to seven years post-combination). The decision to exercise or hold depends on the stock price relative to the strike, the time value left in the warrant, and the warrant holder’s conviction about future stock appreciation. If a merged company is declining and the stock has fallen below $8, warrant holders will almost certainly not exercise, and the warrants will expire worthless. If the company is thriving and the stock is $30, holders have a strong incentive to exercise to own the cheaper shares, especially if they believe the company will keep going higher.
The redemption and sponsor moat
Warrant holders cannot redeem their warrants — that is the key distinction from common shareholders. If a SPAC deal is announced and ordinary shareholders decide to redeem because they lose confidence, warrant holders are forced to stay. That makes warrants riskier from a timing perspective: a warrant holder might believe in the business but see the merged entity destroyed by redemptions (if too many common shares are redeemed, the balance sheet shrinks) or by dilution (if sponsors backstop the deal with significant new capital, warrant holders’ ultimate ownership stake goes down).
The sponsor and its allies often reserve the right to call in the warrants under certain conditions — a forced exercise that converts warrants to shares. This is a contentious feature that has been litigated and negotiated differently across SPAC deals; some sponsors have absolute call rights, while others are constrained. The call right is valuable to sponsors because it can prevent the merged company from being orphaned by warrant expiry if the business is genuinely strong but the warrant holders are slow to exercise.
The trade and the research
Warrant prices are typically quoted separately from the common stock, and the spread between the two reflects the market’s view of the merged company’s prospects. A warrant that trades at $0.50 when the stock is $11.10 (so the stock is only slightly above the $11 strike, and the warrant has $0.10 of intrinsic value) suggests the market is skeptical about meaningful upside. Conversely, a warrant trading at $5 when the stock is $15 suggests the market believes the company will trade much higher, rewarding the leverage the warrant provides.
For an investor considering VACI-WT, the decision is irreducibly speculative: you are buying the right to own more shares if the business thrives, but you are also accepting zero upside if it does not and full downside if it collapses. The warrant holder’s only advantage is the low entry cost and leverage; the cost is illiquidity, dilution risk, and the need to get the underlying business selection and the post-merger execution exactly right. Unlike a common shareholder who can redeem and get their money back, a warrant holder is locked in for the journey.